Squarepoint Ops LLC Rigel Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $307,476 - $431,016	274,533 Added 84.79%	598,324 $885,000
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $218,780 - $474,024	303,862 Added 1524.72%	323,791 $469,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.82 $22,320 - $36,270	19,929 New	19,929 $25,000
Q4 2022 Feb 14, 2023	SELL	$0.67 - $11.9 $361,002 - $6.41 Million	-538,809 Reduced 95.06%	28,006 $42,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $623,496 - $6.92 Million	566,815 New	566,815 $669,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $11,821 - $56,284	-17,644 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $300,090 - $466,357	-135,176 Reduced 88.45%	17,644 $53,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $440,701 - $666,654	-186,738 Reduced 54.99%	152,820 $405,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $273,182 - $351,234	78,052 Added 29.85%	339,558 $1.23 Million
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $501,704 - $737,132	162,364 Added 163.77%	261,506 $1.14 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $332,125 - $488,770	99,142 New	99,142 $339,000
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $526,049 - $837,202	-223,851 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $253,637 - $588,496	-142,493 Reduced 38.9%	223,851 $537,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $339,086 - $492,998	240,487 Added 191.08%	366,344 $670,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $625,862 - $1.48 Million	-492,805 Reduced 79.66%	125,857 $196,000
Q4 2019 Feb 14, 2020	SELL	$1.6 - $2.43 $774,092 - $1.18 Million	-483,808 Reduced 43.88%	618,662 $1.32 Million
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.62 $975,569 - $1.57 Million	598,509 Added 118.76%	1,102,470 $2.06 Million
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $323,709 - $418,257	160,252 Added 46.62%	503,961 $1.32 Million
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $655,080 - $867,981	327,540 Added 2025.73%	343,709 $883,000
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $63,277 - $102,217	-30,422 Reduced 65.3%	16,169 $37,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $112,400 - $155,199	-43,231 Reduced 48.13%	46,591 $150,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $254,196 - $369,168	89,822 New	89,822 $254,000
Q4 2017 Feb 14, 2018	SELL	$3.23 - $4.3 $41,783 - $55,624	-12,936 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $28,200 - $33,245	12,936	12,936 $33,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account